ArdorComm Media Group

Contact Us
logo
Menu
logo
ArdorComm ArdorComm ArdorComm

Health & Wellness Community

Bain Capital Invests $157 Million in Indonesia’s Mayapada Healthcare

Leave a Comment / By / Health & Wellness Community

U.S.-based private investment firm Bain Capital has announced a $157 million investment in Indonesia’s Mayapada Healthcare Group, known as Sejahteraraya Anugrahjaya Tbk PT (SRAJ.JK). The deal, part of Bain Capital’s special situations strategy, will support Mayapada’s hospital expansion through both organic growth and strategic initiatives. The investment is Bain Capital’s first in Indonesia, reflecting growing interest in Southeast Asia’s healthcare sector. The firm’s special situations team, managing over $20 billion in assets, combines credit and equity strategies to target high-growth opportunities. Jonathan Tahir, Mayapada’s chairman and Group CEO, highlighted the demographic trends fueling the healthcare market: “Indonesia faces a growing gap between healthcare supply and demand due to demographic shifts like an aging population and rising affluence.” Sarit Chopra, Bain Capital’s partner and head of special situations in Asia, expressed confidence in Mayapada’s potential, noting that the Indonesian private healthcare market is still in its early stages of development. Founded in 2008, Mayapada Healthcare Group operates seven hospitals across Indonesia, including a flagship hospital in South Jakarta with over 1,000 beds. The group plans to increase its capacity to over 2,000 beds by 2027, supported by ongoing projects. Shares of Mayapada Healthcare have soared 747% year-to-date, signaling strong market optimism. The transaction is expected to close in early 2025, subject to regulatory and shareholder approvals. With this investment, Bain Capital taps into Southeast Asia’s rising affluence and aging population, positioning itself in a resilient sector amid global economic challenges. Source: Reuters Photo Credit: Reuters  

Over 1 in 5 Adults Worldwide Infected with Genital Herpes: WHO

Leave a Comment / By / Health & Wellness Community

According to the World Health Organization (WHO), over 846 million people aged 15 to 49, or more than one in five individuals in this age group, are living with genital herpes infections globally. These findings, published in the journal Sexually Transmitted Infections, highlight the widespread nature of the infection and underscore the urgent need for improved prevention, treatment, and vaccine development. Each year, an estimated 42 million people contract a new genital herpes infection, equating to one new case every second. While many infections are asymptomatic, over 200 million individuals in 2020 experienced painful genital sores and blisters, often requiring repeated medical visits. Dr. Meg Doherty, WHO’s Director of Global HIV, Hepatitis, and STI Programmes, emphasized the strain on global health systems: “Genital herpes causes pain and distress for millions, and better prevention and treatment options are critical to controlling its spread and reducing its health impacts, including its link to an increased risk of HIV transmission.” The study estimates 520 million people have genital HSV-2, responsible for 90% of symptomatic cases and associated with a three-fold higher HIV risk. An additional 376 million are infected with genital HSV-1, which is increasingly transmitted during adulthood due to declining childhood oral infections. Herpes infections carry significant social and economic burdens. Stigma often silences discussions about the infection, and healthcare costs and productivity losses are estimated at $35 billion annually. WHO advocates consistent condom use and avoiding sexual contact during active outbreaks to reduce transmission. It also recommends HIV testing for individuals with genital herpes and pre-exposure prophylaxis when needed. Research into vaccines and new treatments remains a priority, as these advancements could significantly improve global health outcomes and reduce the stigma surrounding herpes infections. Source: World Health Organization Photo Credit: World Health Organization

Max Healthcare Hits All-Time High Stock Price of ₹1124.9

Leave a Comment / By / Health & Wellness Community

Max Healthcare Institute, a leading provider in the hospital and healthcare services sector, achieved a significant milestone as its stock price reached an all-time high of ₹1124.9 on December 10, 2024. This impressive performance underscores the company’s strong market position and growth potential. Key Highlights Stock Performance: The stock has shown a 15.49% gain over the past 7 days, maintaining consistent upward momentum. Current Recommendation: MarketsMojo has issued a ‘Hold’ call for Max Healthcare, reflecting its steady alignment with the broader market trends. Moving Averages: The stock price exceeds its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signaling strong technical performance. Comparative Growth Max Healthcare’s 1-year performance of 64.79% stands out significantly against the Sensex’s 16.72% growth over the same period. This remarkable growth reinforces the company’s robust standing in the healthcare sector. Market Stability The stock’s consistent trading price and long-term upward trajectory highlight its stability and appeal as a reliable investment option. Industry Leadership As a large-cap entity, Max Healthcare Institute continues to set benchmarks in the healthcare services industry, showcasing profitability and resilience. With its current trajectory, the company remains well-positioned for sustained success and growth in the future. Investors and market analysts are closely watching Max Healthcare, which has emerged as a top contender in the healthcare sector, offering both stability and promising returns. Source: marketsmojo Photo Credit: marketsmojo

MediBuddy Launches BuddyCare to Revolutionize Cashless Healthcare

Leave a Comment / By / Health & Wellness Community

MediBuddy has unveiled BuddyCare, a networking platform under the India Health Care Collaborators (IHCC) initiative, to strengthen India’s cashless primary healthcare infrastructure. This innovative platform connects insurance companies, healthcare providers, and intermediaries, fostering a robust ecosystem in alignment with India’s ‘Insurance for All by 2047’ vision. BuddyCare offers comprehensive services for insurers, including pre-policy issuance, real-time risk quantification, and seamless post-policy health and wellness service delivery. By integrating advanced fraud-resilient systems like the ‘Sherlock’ Fraud Detection System, BuddyCare enhances transparency and efficiency in outpatient department (OPD) processes. Satish Kannan, Co-founder and CEO of MediBuddy, emphasized the platform’s significance, stating, “IHCC marks a transformative step in redefining healthcare delivery in India. By integrating innovation, collaboration, and quality, we aim to create a universally accessible, cashless, and insurance-integrated healthcare model.” With a network of over 100,000 doctors, IHCC bridges gaps between life, health, and wellness insurance. Leveraging AI-driven tools, the platform improves risk management and service delivery while offering medical consultations, diagnostics, medicine delivery, and concierge support. MediBuddy also extends its reach to Non-Resident Indians (NRIs), ensuring inclusive healthcare solutions. As part of its Corporate Social Responsibility (CSR) initiatives, the company runs paramedical training programs to bolster healthcare infrastructure nationwide. This initiative not only supports MediBuddy’s mission but also aligns with national policy objectives. By integrating technology and strategic partnerships, BuddyCare is set to redefine healthcare delivery across urban and rural India, ensuring greater accessibility, affordability, and efficiency. Source: expresshealthcare Photo Credit: expresshealthcare

Hospitals Secure 50% Share in Healthcare FDI, Driving Sector Growth

Leave a Comment / By / Health & Wellness Community

Foreign direct investment (FDI) in India’s healthcare sector has seen a significant shift, with hospitals now commanding 50% of the total FDI in FY24, amounting to $1.5 billion. This marks a substantial rise from 24% in FY21, signaling a growing investor preference for hospitals over the traditionally dominant pharmaceuticals sector. Post-Covid, hospitals and diagnostics have emerged as key areas for investment, driven by rising demand for quality healthcare, increased insurance coverage, and untapped potential in underserved regions. The surge has led to high-profile transactions such as Temasek’s $2 billion acquisition of an additional 41% stake in Manipal Hospitals, valuing the chain at $4.8 billion. “The Indian market’s size, high disease burden, and growing insurance penetration make it an attractive destination for investors,” said Sujay Shetty, Global Health Industries Advisory Leader, PwC India. “The hospital sector’s reinvestment in infrastructure further supports its robust growth trajectory.” Prominent hospital chains like Max Healthcare are spearheading expansion plans, with the group investing over ₹5,000 crore to double its capacity in the next three years. Abhay Soi, CMD of Max Healthcare, emphasized the capital-intensive nature of the sector and its critical role in achieving India’s $5 trillion economy target. Investor interest has also been buoyed by successful primary market transactions, including IPOs of six hospital chains, raising around ₹3,600 crore through IPOs and qualified institutional placements (QIPs). This influx of funds is expected to boost bed capacity among the 10 listed hospital firms by 47% over FY24-27, with expansions concentrated in north and south India, according to BNP Paribas analyst Tausif Shaikh. The momentum highlights a transformative era for India’s healthcare landscape, with hospitals at the forefront of FDI-driven growth, paving the way for enhanced healthcare access and infrastructure development nationwide. Source: Times of India Photo Credit: Times of India

Aster DM and CARE Hospitals Join Forces in India’s Biggest Healthcare Deal

Leave a Comment / By / Health & Wellness Community

In a landmark healthcare merger, Aster DM Healthcare and Blackstone-backed CARE Hospitals have united to form Aster DM Quality Care, a top-tier player in India’s healthcare industry. With an enterprise value of ₹43,000 crore ($5 billion), the merged entity will rank among India’s top three hospital chains, alongside Apollo and Manipal Hospitals. The merger will consolidate 38 hospitals across 27 cities, with plans to expand capacity to 13,300 beds by FY27, adding 3,500 new beds. Revenue for the combined entity is estimated at ₹7,314 crore. Deal Structure and Shareholding Aster DM will acquire 19 million equity shares of Quality Care India Ltd. (QCIL) from Blackstone and Centella at ₹445.8 per share, issuing 18.6 million shares to QCIL shareholders at ₹456.33 per share. The swap ratio for the merger entails QCIL shareholders receiving 977 Aster shares for every 1,000 QCIL shares. Post-merger, the shareholding structure will see Blackstone holding 30.7%, Aster promoters 24%, and the remaining 45.3% with the public and other shareholders. Leadership and Vision Azad Moopen, founder and chairman of Aster DM Healthcare, will continue as executive chairman of the merged entity, while CARE Hospitals’ Varun Khanna will assume the role of managing director and group CEO. “This merger combines the strengths of two pioneers, creating a transformative force in the healthcare sector. We aim to redefine patient care, innovation, and accessibility,” Moopen stated. Strategic Focus The new entity plans to integrate strengths, expand its footprint, and set benchmarks in patient-centric care. Amit Dixit, Blackstone’s head of Asia Private Equity, highlighted their commitment to scaling the platform into a world-class healthcare institution. Vishal Bali, senior advisor at TPG, praised the partnership as a significant milestone for India’s multi-specialty hospital ecosystem. Regulatory Approvals and Timeline The merger, expected to close by Q3 FY26, is subject to shareholder and regulatory approvals. This deal marks a transformative chapter in India’s healthcare sector, setting the stage for significant advancements in care delivery and infrastructure. Source: Business Standard Photo Credit: Business Standard

Trump Appoints Indian-Origin Covid Critic Jay Bhattacharya as NIH Director

Leave a Comment / By / Health & Wellness Community

Former U.S. President Donald Trump has nominated Dr. Jay Bhattacharya, an Indian-origin Stanford academic and prominent critic of COVID-19 lockdown policies, as the Director of the National Institutes of Health (NIH). The NIH, a leading public funder of medical research, manages an annual budget of $47.3 billion and plays a critical role in shaping U.S. health policies. Announcing the appointment, Trump stated that Dr. Bhattacharya, in collaboration with Robert F. Kennedy Jr., would lead efforts to restore the NIH’s reputation as the “Gold Standard of Medical Research.” The new leadership aims to tackle America’s pressing health crises, particularly chronic illnesses and diseases. Who is Jay Bhattacharya? Born in Kolkata in 1968, Dr. Bhattacharya is an accomplished scholar with a dual academic foundation: a medical doctorate (1997) and a Ph.D. in economics (2000), both from Stanford University. Currently, he serves as a Professor of Health Policy at Stanford University and directs the Center for Demography and Economics of Health and Aging. Dr. Bhattacharya’s research focuses on the health and economic well-being of vulnerable populations, the impact of government programs, and biomedical innovation. He gained national attention during the COVID-19 pandemic for co-authoring the Great Barrington Declaration in October 2020, advocating for targeted protections for high-risk groups rather than widespread lockdowns. A prolific researcher, Dr. Bhattacharya has authored 135 peer-reviewed articles across various fields, including medicine, health policy, and economics. His appointment signals a shift toward addressing systemic health challenges and reevaluating pandemic response strategies in the United States. Dr. Bhattacharya’s nomination marks a significant move, blending innovative health policies with a critical lens on past approaches, as the NIH positions itself to address evolving medical and research challenges. Source: NDTV Photo Credit: NDTV

GST Collection on Health, Life Insurance Services Reaches ₹16,398 Crore in FY24

Leave a Comment / By / Health & Wellness Community

The Union Government’s Goods and Services Tax (GST) revenue from healthcare and life insurance services reached ₹16,398 crore in FY24, marking a massive 680% increase from ₹2,101 crore in FY20, according to Minister of State for Finance Pankaj Chaudhary’s written reply in the Lok Sabha on Monday. However, collections for FY24 saw a slight dip compared to ₹16,770 crore in FY23. Current GST Rates and Exemptions: GST on health insurance services is levied at 18%. Exemptions are provided for specific schemes like Rashtriya Swasthya Bima Yojana (RSBY), Universal Health Insurance Scheme, Jan Arogya Bima Policy, and Niramaya Health Insurance Scheme, targeting economically weaker sections and differently abled individuals. Demands for GST Rate Reduction: The figures come amidst rising demands from stakeholders, including state governments, to reduce GST rates on health and life insurance premiums. Group of Ministers (GoM) on Health Insurance: Bihar Deputy Chief Minister and Finance Minister Samrat Choudhary has been appointed convenor of a Group of Ministers (GoM) tasked with addressing GST issues related to health insurance. The GoM is set to submit its report to the GST Council at its next meeting in Jaisalmer on December 21, 2024. Chaudhary noted that the GST Council, during its 54th meeting in September 2024, recommended forming the GoM after extensive deliberations on the matter. GST on Education Services: In a related update, GST revenue from non-exempted education services, such as commercial training and coaching, rose by 67% over the past three years. FY24 collection: ₹4,792.40 crore FY22 collection: ₹2,859.49 crore Notably, printed books, Braille books, newspapers, journals, and children’s picture books continue to attract nil GST, reinforcing the government’s commitment to making education more accessible. The GST Council’s upcoming meeting and the GoM’s recommendations will be crucial in determining whether these rates undergo revision to balance fiscal objectives with stakeholder concerns. Source: Business Standard Photo Credit: Business Standard

Gurugram Health Department Launches Pollution Awareness Drive

Leave a Comment / By / Health & Wellness Community

The Gurugram health department has launched an awareness campaign to help residents safeguard against pollution-induced health risks as the city’s Air Quality Index (AQI) improved slightly to a “very poor” reading of 374 on Wednesday, down from Tuesday’s “severe” 402 and Monday’s alarming 469, according to the Central Pollution Control Board (CPCB). Residents are being urged to monitor air quality daily through mobile applications and take precautions, such as using masks, air purifiers, and humidifiers. Officials recommend limiting outdoor activities during peak pollution hours and switching to cleaner cooking fuels, reducing diesel generator usage, and relying more on public transport to minimize emissions. Chief Medical Officer Dr. Virender Yadav emphasized, “Our aim is to empower people with the right knowledge to protect themselves during these critical times.” Manish Rathee, Medical Superintendent of Civil Hospital, Sector 10, highlighted their focus on outreach in underserved areas to ensure awareness reaches vulnerable groups. Doctors are also stressing the importance of early detection of symptoms like coughing, wheezing, and chest discomfort, urging immediate medical attention to prevent severe respiratory or cardiovascular complications. For children and the elderly, who are most vulnerable, parents and caregivers are advised to restrict outdoor activities during high pollution hours, ensure adequate hydration, and maintain clean indoor air. “Simple measures such as drinking more water and avoiding strenuous outdoor activities can make a significant difference,” said Dr. Kajal Kumud from Civil Hospital, Sector 10. The campaign underscores the importance of community action and individual responsibility to mitigate health risks during Gurugram’s ongoing pollution crisis. Source: Hindustan Times Photo Credit: Hindustan Times

India’s Healthcare Infrastructure Witnesses Post-Pandemic Growth

Leave a Comment / By / Health & Wellness Community

India’s healthcare infrastructure has experienced remarkable growth since the pandemic, according to a report by Pharmarack. Over the past five years, the number of hospitals has surged from 43,500 in 2019 to 54,000 in 2024, with private hospitals leading the growth at 27%. This rise has contributed to an increase in hospital beds from 1.1 million to 1.3 million during the same period, with projections estimating 1.7 million beds by 2030. Medical education has also expanded significantly. The number of medical colleges has grown from 387 in 2014, offering 51,348 seats, to 706 colleges with 109,145 seats in 2024. Similarly, nursing colleges have increased from 5,700 to 8,692 over the last decade, reflecting a strong push toward building healthcare capacity. Despite these advancements, challenges remain. A staggering 70% of India’s population resides in rural areas, yet only 25% of healthcare facilities cater to these regions. However, the adoption of pandemic-driven innovations like online pharmacies, teleconsultations, and government health initiatives is gradually bridging the gap, said Sheetal Sapale, VP (Commercial) at Pharmarack. The online pharmacy sector has seen explosive growth, expanding nearly four-fold from $512 million in 2018 to $2 billion in 2024. While initially growing at 10-15% annually, the sector peaked at 60% growth during the pandemic before stabilizing at 20%. “Online pharmacies have become especially popular among chronic illness patients for their discounts and convenience,” the report noted. With partnerships for last-mile delivery and options like cash-on-delivery and e-payments, these platforms are reaching semi-urban and rural regions, driving accessibility across the country. Source: financialexpress Photo Credit: financialexpress